The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente
Abstract
The interface between an infectious agent and its host represents the ultimate battleground for survival: The microbe must secure a niche for replication, whereas the host must limit the pathogen's advance. Among the host's arsenal of antimicrobial factors, the type 1 interferons (IFNs) induce potent defense mechanisms against viruses and are key in the host-virus standoff. Viruses have evolved multiple tricks to avoid the immediate antiviral effects of IFNs and, in turn, hosts have adapted use of this innate cytokine system to galvanize multiple additional layers of immune defense. The plasticity that exists in these interactions provides us with a lesson in détente.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
Cited by
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
Ye, Q., Wang, B., & Mao, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.037 · Cited by 2,761
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210
Antiviral Immunity Directed by Small RNAs
Ding, S.-W., & Voinnet, O. (2007) · Cell · doi:10.1016/j.cell.2007.07.039 · Cited by 1,521
Type I Interferons in Host Defense
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.007 · Cited by 1,195
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Gilliet, M., Cao, W., & Liu, Y.-J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2358 · Cited by 1,190
“Third, type I IFNs induce the expression of a variety of genes with antiviral function”
BackgroundInterferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
The unique immunological and microbial aspects of pregnancy
Mor, G., Aldo, P., & Alvero, A. B. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.64 · Cited by 1,041
Knoops, K., Kikkert, M., Worm, S. H. E. V. D., Zevenhoven-Dobbe, J. C., van der Meer, Y., Koster, A. J., Mommaas, A. M., & Snijder, E. J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060226 · Cited by 1,015
Gack, M. U., Albrecht, R. A., Urano, T., Inn, K.-S., Huang, I.-C., Carnero, E., Farzan, M., Inoue, S., Jung, J. U., & García-Sastre, A. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.006 · Cited by 876
Teijaro, J. R., Walsh, K. B., Cahalan, S., Fremgen, D. M., Roberts, E., Scott, F., Martinborough, E., Peach, R., Oldstone, M. B. A., & Rosen, H. (2011) · Cell · doi:10.1016/j.cell.2011.08.015 · Cited by 688
Kopecky-Bromberg, S. A., Martínez-Sobrido, L., Frieman, M., Baric, R. A., & Palese, P. (2007) · Journal of Virology · doi:10.1128/jvi.01782-06 · Cited by 673
Mibayashi, M., Martínez-Sobrido, L., Loo, Y.-M., Cárdenas, W. B., Gale, M., & García-Sastre, A. (2007) · Journal of Virology · doi:10.1128/jvi.01265-06 · Cited by 576
Self-citationComplex modulation of cell type-specific signaling in response to type I interferons
van Boxel-Dezaire, A. H. H., Rani, M. R. S., & Stark, G. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.014 · Cited by 530
Frieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S. A., Palese, P., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.01012-07 · Cited by 507
Host Innate Immune Receptors and Beyond: Making Sense of Microbial Infections
Ishii, K. J., Koyama, S., Nakagawa, A., Coban, C., & Akira, S. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.003 · Cited by 499
Regulation of antiviral T cell responses by type I interferons
Crouse, J., Kalinke, U., & Oxenius, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3806 · Cited by 479
The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
Li, J.-Y., Liao, C.-H., Wang, Q., Tan, Y.-J., Luo, R., Qiu, Y., & Ge, X.-Y. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198074 · Cited by 461
Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein
Kochs, G., García-Sastre, A., & Martínez-Sobrido, L. (2007) · Journal of Virology · doi:10.1128/jvi.02581-06 · Cited by 445
Self-citationNutrition, immunity and COVID-19
Calder, P. C. (2020) · BMJ Nutrition, Prevention & Health · doi:10.1136/bmjnph-2020-000085 · Cited by 426
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
Hammer, Q., Rückert, T., Borst, E. M., Dunst, J., Haubner, A., Durek, P., Heinrich, F., Gasparoni, G., Babic, M., Tomic, A., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0082-6 · Cited by 423
Oncolytic viruses as engineering platforms for combination immunotherapy
Twumasi-Boateng, K., Pettigrew, J. L., Kwok, Y. Y. E., Bell, J. C., & Nelson, B. H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0009-4 · Cited by 417
Devaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704870200 · Cited by 411
Swiecki, M., Gilfillan, S., Vermi, W., Wang, Y., & Colonna, M. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.020 · Cited by 381
Zhang, Z., Kim, T., Bao, M., Facchinetti, V., Jung, S. Y., Ghaffari, A. A., Qin, J., Cheng, G., & Liu, Y.-J. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.027 · Cited by 375
Pathogenic potential of interferon αβ in acute influenza infection
Davidson, S., Crotta, S., McCabe, T. M., & Wack, A. (2014) · Nature Communications · doi:10.1038/ncomms4864 · Cited by 369
Zhu, J., Huang, X., & Yang, Y. (2007) · Journal of Virology · doi:10.1128/jvi.02192-06 · Cited by 366
Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
Thomas, C., Moraga, I., Levin, D., Krutzik, P. O., Podoplelova, Y., Trejo, A., Lee, C., Yarden, G., Vleck, S. E., Glenn, J. S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.048 · Cited by 356
Bai, Z., Cao, Y., Liu, W., & Li, J. (2021) · Viruses · doi:10.3390/v13061115 · Cited by 348
Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity
tenOever, B. R., Ng, S.-L., Chua, M. A., McWhirter, S. M., García-Sastre, A., & Maniatis, T. (2007) · Science · doi:10.1126/science.1136567 · Cited by 342
Self-citationHabjan, M., Andersson, I., Klingström, J., Schümann, M., Martin, A., Zimmermann, P., Wagner, V., Pichlmair, A., Schneider, U., Mühlberger, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002032 · Cited by 331
Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.12998 · Cited by 324
Translational control of the innate immune response through IRF-7
Colina, R., Costa-Mattioli, M., Dowling, R. J. O., Jaramillo, M., Tai, L.-H., Breitbach, C. J., Martineau, Y., Larsson, O., Rong, L., Svitkin, Y. V., et al. (2008) · Nature · doi:10.1038/nature06730 · Cited by 316
Bradley, K. C., Finsterbusch, K., Schnepf, D., Crotta, S., Llorian, M., Davidson, S., Fuchs, S. Y., Staeheli, P., & Wack, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.105 · Cited by 313
Koyama, S., Ishii, K. J., Kumar, H., Tanimoto, T., Coban, C., Uematsu, S., Kawai, T., & Akira, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4711 · Cited by 309
Cholesterol Manipulation by West Nile Virus Perturbs the Cellular Immune Response
Mackenzie, J. M., Khromykh, A. A., & Parton, R. G. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.003 · Cited by 308
Rajsbaum, R., Albrecht, R. A., Wang, M. K., Maharaj, N. P., Versteeg, G. A., Nistal-Villán, E., García-Sastre, A., & Gack, M. U. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003059 · Cited by 305
Role of Tissue Protection in Lethal Respiratory Viral-Bacterial Coinfection
Jamieson, A. M., Pasman, L., Yu, S., Gamradt, P., Homer, R. J., Decker, T., & Medzhitov, R. (2013) · Science · doi:10.1126/science.1233632 · Cited by 292
Di Pucchio, T., Chatterjee, B., Smed-Sörensen, A., Clayton, S., Palazzo, A., Montes, M., Xue, Y., Mellman, I., Banchereau, J., & Connolly, J. E. (2008) · Nature Immunology · doi:10.1038/ni.1602 · Cited by 291
Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles
Kanasty, R. L., Whitehead, K. A., Vegas, A. J., & Anderson, D. G. (2012) · Molecular Therapy · doi:10.1038/mt.2011.294 · Cited by 279
Epigenetic control of innate and adaptive immune memory
Lau, C. M., Adams, N. M., Geary, C. D., Weizman, O.-E., Rapp, M., Pritykin, Y., Leslie, C. S., & Sun, J. C. (2018) · Nature Immunology · doi:10.1038/s41590-018-0176-1 · Cited by 278
Yang, Y., Zhang, L., Geng, H., Deng, Y., Huang, B., Guo, Y., Zhao, Z., & Tan, W. (2013) · Protein & Cell · doi:10.1007/s13238-013-3096-8 · Cited by 277
Bidet, K., Dadlani, D., & Garcia-Blanco, M. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004242 · Cited by 276
Virus Recognition by Toll-7 Activates Antiviral Autophagy in Drosophila
Nakamoto, M., Moy, R. H., Xu, J., Bambina, S., Yasunaga, A., Shelly, S. S., Gold, B., & Cherry, S. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.003 · Cited by 276
Evolutionary Origins of cGAS-STING Signaling
Margolis, S. R., Wilson, S. C., & Vance, R. E. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.03.004 · Cited by 276
MERS-CoV: Understanding the Latest Human Coronavirus Threat
Chafekar, A., & Fielding, B. (2018) · Viruses · doi:10.3390/v10020093 · Cited by 276
Influenza A Virus Inhibits Type I IFN Signaling via NF-κB-Dependent Induction of SOCS-3 Expression
Pauli, E.-K., Schmolke, M., Wolff, T., Viemann, D., Roth, J., Bode, J. G., & Ludwig, S. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000196 · Cited by 275
MacNeil, A., Nichol, S. T., & Spiropoulou, C. F. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.017 · Cited by 275
Zhao, L., Jha, B. K., Wu, A., Elliott, R., Ziebuhr, J., Gorbalenya, A. E., Silverman, R. H., & Weiss, S. R. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.011 · Cited by 273
Mucosal immune responses to infection and vaccination in the respiratory tract
Mettelman, R. C., Allen, E. K., & Thomas, P. G. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.013 · Cited by 271
Beura, L. K., Sarkar, S. N., Kwon, B., Subramaniam, S., Jones, C., Pattnaik, A. K., & Osorio, F. A. (2010) · Journal of Virology · doi:10.1128/jvi.01326-09 · Cited by 270
Meyer-Wentrup, F., Benitez-Ribas, D., Tacken, P. J., Punt, C. J. A., Figdor, C. G., de Vries, I. J. M., & Adema, G. J. (2008) · Blood · doi:10.1182/blood-2007-03-081398 · Cited by 270
Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In Vivo
Jewell, N. A., Cline, T., Mertz, S. E., Smirnov, S. V., Flaño, E., Schindler, C., Grieves, J. L., Durbin, R. K., Kotenko, S. V., & Durbin, J. E. (2010) · Journal of Virology · doi:10.1128/jvi.01703-09 · Cited by 263
Gack, M. U., Kirchhofer, A., Shin, Y. C., Inn, K.-S., Liang, C., Cui, S., Myong, S., Ha, T., Hopfner, K.-P., & Jung, J. U. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804947105 · Cited by 261
Steel, J., Lowen, A. C., Pena, L., Angel, M., Solórzano, A., Albrecht, R., Perez, D. R., García-Sastre, A., & Palese, P. (2009) · Journal of Virology · doi:10.1128/jvi.01920-08 · Cited by 258
Self-citationInnate Immune Responses to AAV Vectors
Rogers, G. L., Martino, A. T., Aslanidi, G. V., Jayandharan, G. R., Srivastava, A., & Herzog, R. W. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00194 · Cited by 178
Targeting the TLR9–MyD88 pathway in the regulation of adaptive immune responses
Huang, X., & Yang, Y. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.501333 · Cited by 121
Association of social and cognitive impairment and biomarkers in autism spectrum disorders
Alabdali, A., Al-Ayadhi, L., & El-Ansary, A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-4 · Cited by 117
Interferons induce an antiviral state in human pancreatic islet cells
Hultcrantz, M., Hühn, M. H., Wolf, M., Olsson, A., Jacobson, S., Williams, B. R., Korsgren, O., & Flodström-Tullberg, M. (2007) · Virology · doi:10.1016/j.virol.2007.05.010 · Cited by 98
“The type I IFNs, acting locally and systemically, contribute to the antiviral response by inducing an antiviral state in uninfected cells, and by triggering apoptosis in already infected cells (Garcia-Sastre and Biron, 2006).”
BackgroundCritical illness in children with influenza A/pH1N1 2009 infection in Canada*
Jouvet, P., Hutchison, J., Pinto, R., Menon, K., Rodin, R., Choong, K., Kesselman, M., Veroukis, S., André Dugas, M., Santschi, M., et al. (2010) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3181d9c80b · Cited by 60
Interferon-β1bin multiple sclerosis
Buttmann, M., & Rieckmann, P. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.3.227 · Cited by 43
Antiviral-activated dendritic cells: a paracrine-induced response state
Bordería, A. V., Hartmann, B. M., Fernandez-Sesma, A., Moran, T. M., & Sealfon, S. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6872 · Cited by 30
Takatsuki, H., Taguchi, F., Nomura, R., Kashiwazaki, H., Watanabe, M., Ikehara, Y., & Watanabe, R. (2009) · Neuropathology · doi:10.1111/j.1440-1789.2009.01082.x · Cited by 14
Metadata
- Authors
- García-Sastre, A., & Biron, C. A.
- Venue
- Science
- Published
- 2006-05-12
- Volume
- 312
- Issue
- 5775
- Pages
- 879-882
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2088534886
- Cited by
- 885
- References
- 53
- FWCI
- 24.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.